TerrAscend Corp. (TSX:TSND)
0.9100
+0.0100 (1.11%)
Jul 3, 2026, 3:59 PM EST
TerrAscend Market Cap
TerrAscend has a market cap or net worth of CAD 281.7 million as of July 6, 2026. Its market cap has increased by 158.51% in one year.
Market Cap
281.70M
Enterprise Value
585.29M
Revenue
365.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.91
Market Cap Chart
Since May 3, 2017, TerrAscend's market cap has increased from 35.38M to 281.70M, an increase of 696.28%. That is a compound annual growth rate of 25.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 281.70M | -6.47% |
| Dec 31, 2025 | 301.20M | 12.48% |
| Dec 31, 2024 | 267.77M | -57.63% |
| Dec 29, 2023 | 632.00M | 57.35% |
| Dec 30, 2022 | 401.64M | -72.92% |
| Dec 31, 2021 | 1.48B | -24.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipher Pharmaceuticals | 436.08M |
| Cresco Labs | 429.02M |
| Aurora Cannabis | 253.34M |
| Auxly Cannabis Group | 250.87M |
| Organigram Global | 204.12M |
| Cannara Biotech | 180.77M |
| Cardiol Therapeutics | 176.37M |
| BioSyent | 165.86M |